In this video interview, Jeff Sidell, PhD, chief technology officer, Advarra, highlights how integration can simplify processes.
In a recent video interview with Applied Clinical Trials, Jeff Sidell, PhD, chief technology officer, Advarra, discussed current challenges in clinical research technology. He highlighted the overabundance of systems and emphasized the need for integration to streamline processes and reduce administrative overhead. Sidell also discussed the potential of AI, particularly predictive analytics, to automate repetitive tasks, enhancing efficiency and quality.
A transcript of Sidell’s conversation with ACT can be found below.
ACT: How can stakeholders address some of the technology overload industry is currently experiencing?
Sidell: One simple answer is integration. I've been in technology for long enough that I've seen when there's an integration play, so we're going integrate all these systems together, and you'll only have to log on once, and you only have to enter data once, and it's a good idea, but there's always a struggle, whose integration are you going to use? It's sort of like, who's going to be the first among equals? I still think it's possible. I think that, Advarra, for example, is in a good position to because we start at the very beginning of a clinical trial, when a protocol document is submitted to the IRB (institutional review board), all the way through to the conduct of the trial at the sites. Just like everybody else, we're going to make a play to be the integration provider. I think we're a little farther along than some of the other solution providers, but it's going to be a horse race.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.